End-of-day quote
Taiwan S.E.
23:00:00 13/06/2024 BST
|
5-day change
|
1st Jan Change
|
20.55
TWD
|
-0.48%
|
|
+0.74%
|
-1.67%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
7,314
|
6,130
|
7,441
|
11,019
|
10,614
|
9,970
|
Enterprise Value (EV)
1 |
9,493
|
8,541
|
8,763
|
12,270
|
11,702
|
11,565
|
P/E ratio
|
19.5
x
|
29.5
x
|
13.4
x
|
11.7
x
|
9.8
x
|
23.8
x
|
Yield
|
3.38%
|
3.89%
|
7.69%
|
6.49%
|
8.09%
|
2.87%
|
Capitalization / Revenue
|
0.75
x
|
0.7
x
|
0.88
x
|
1.2
x
|
1
x
|
1.06
x
|
EV / Revenue
|
0.97
x
|
0.97
x
|
1.03
x
|
1.33
x
|
1.11
x
|
1.23
x
|
EV / EBITDA
|
13.6
x
|
15
x
|
8.88
x
|
8.41
x
|
9.37
x
|
17.9
x
|
EV / FCF
|
-10.7
x
|
13.8
x
|
6.89
x
|
48.1
x
|
17.5
x
|
22.4
x
|
FCF Yield
|
-9.33%
|
7.23%
|
14.5%
|
2.08%
|
5.73%
|
4.47%
|
Price to Book
|
1.04
x
|
0.89
x
|
1.04
x
|
1.45
x
|
1.28
x
|
1.25
x
|
Nbr of stocks (in thousands)
|
469,451
|
477,016
|
477,016
|
477,016
|
477,016
|
477,016
|
Reference price
2 |
15.58
|
12.85
|
15.60
|
23.10
|
22.25
|
20.90
|
Announcement Date
|
29/03/19
|
31/03/20
|
29/03/21
|
29/03/22
|
27/03/23
|
15/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
9,785
|
8,797
|
8,482
|
9,199
|
10,571
|
9,432
|
EBITDA
1 |
696.9
|
569.5
|
987.1
|
1,458
|
1,249
|
647.8
|
EBIT
1 |
492.6
|
303.9
|
708.8
|
1,219
|
1,029
|
433.7
|
Operating Margin
|
5.03%
|
3.45%
|
8.36%
|
13.25%
|
9.73%
|
4.6%
|
Earnings before Tax (EBT)
1 |
523.1
|
297.7
|
713.4
|
1,010
|
1,342
|
495.4
|
Net income
1 |
380.1
|
215.3
|
554.8
|
947.6
|
1,085
|
418.2
|
Net margin
|
3.88%
|
2.45%
|
6.54%
|
10.3%
|
10.26%
|
4.43%
|
EPS
2 |
0.7984
|
0.4350
|
1.160
|
1.980
|
2.270
|
0.8767
|
Free Cash Flow
1 |
-885.6
|
617.3
|
1,271
|
255.1
|
670.2
|
517.1
|
FCF margin
|
-9.05%
|
7.02%
|
14.99%
|
2.77%
|
6.34%
|
5.48%
|
FCF Conversion (EBITDA)
|
-
|
108.39%
|
128.79%
|
17.49%
|
53.67%
|
79.82%
|
FCF Conversion (Net income)
|
-
|
286.78%
|
229.15%
|
26.92%
|
61.79%
|
123.65%
|
Dividend per Share
2 |
0.5263
|
0.5000
|
1.200
|
1.500
|
1.800
|
0.6000
|
Announcement Date
|
29/03/19
|
31/03/20
|
29/03/21
|
29/03/22
|
27/03/23
|
15/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,180
|
2,411
|
1,321
|
1,251
|
1,089
|
1,595
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.128
x
|
4.234
x
|
1.338
x
|
0.8579
x
|
0.8717
x
|
2.462
x
|
Free Cash Flow
1 |
-886
|
617
|
1,271
|
255
|
670
|
517
|
ROE (net income / shareholders' equity)
|
5.1%
|
2.82%
|
7.32%
|
11.9%
|
13.1%
|
4.9%
|
ROA (Net income/ Total Assets)
|
2.82%
|
1.68%
|
3.95%
|
6.71%
|
5.17%
|
2.14%
|
Assets
1 |
13,458
|
12,798
|
14,047
|
14,125
|
20,967
|
19,564
|
Book Value Per Share
2 |
15.00
|
14.40
|
15.00
|
16.00
|
17.30
|
16.70
|
Cash Flow per Share
2 |
0.5400
|
0.7300
|
2.020
|
1.360
|
2.520
|
1.020
|
Capex
1 |
560
|
209
|
128
|
112
|
86.6
|
58.4
|
Capex / Sales
|
5.72%
|
2.37%
|
1.51%
|
1.22%
|
0.82%
|
0.62%
|
Announcement Date
|
29/03/19
|
31/03/20
|
29/03/21
|
29/03/22
|
27/03/23
|
15/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -1.67% | 303M | | -0.52% | 98.49B | | -10.90% | 58.77B | | +63.33% | 45.23B | | +12.56% | 37.42B | | -1.62% | 30.46B | | +7.05% | 19.26B | | +11.98% | 16.67B | | +6.45% | 13.6B | | -6.76% | 12.73B |
Other Commodity Chemicals
|